Skip to main content
Caplight Logo









EnoPace Biomedical

EnoPace Biomedical

Private
CaesareaHealthcare & Life Scienceshttps://www.enopace.com/

Last Round

Early Funding

Jul 15, 2013

Total Funding Raised

$25M

Company Overview

EnoPace Biomedical operates in Healthcare & Life Sciences and is based in Caesarea. Its latest recorded funding round was an Early Funding round in July 2013.

EnoPace Biomedical is a medical device company that develops minimally invasive, implantable neurostimulation systems for the treatment of congestive heart failure.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Biotechnology, Clinical Trials

Business Model

B2B

Customer Profile

Hardware Sales

AI Layer

Non-AI

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Pricing history

Caplight clients see full MarketPrice™ history and secondary transactions.

Book a demo

For institutional investors. Book with your work email.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

Momentum history

Caplight clients track how buyer interest and sentiment change over time.

Book a demo

For institutional investors. Book with your work email.

EnoPace Biomedical Comparables

Compare EnoPace Biomedical with similar companies based on industry and business-model similarity.

EnoPace Biomedical comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Berlin Heals Holding AG
82%
BioControl Medical
80%
アドリアカイム株式会社
77%
Book a demo to see all comparables

For institutional investors. Book with your work email.

EnoPace Biomedical Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Early FundingJul 15, 2013
Early FundingFeb 28, 2013
Early FundingOct 17, 2011
Book a demo to see all funding rounds

For institutional investors. Book with your work email.

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jul 15, 2013

    Raised $5M in early funding.

  • Feb 28, 2013

    Raised $13M in early funding.

Book a demo to see all signals

For institutional investors. Book with your work email.

EnoPace Biomedical Filings

Explore SEC and related filing metadata, where available.

EnoPace Biomedical filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Book a demo

For institutional investors. Book with your work email.

Frequently Asked Questions

Common questions about EnoPace Biomedical's valuation, stock price, and market status.

Is EnoPace Biomedical a public or private company?

EnoPace Biomedical is a private company.

What is the current stock price of EnoPace Biomedical?

EnoPace Biomedical is a private company, so its shares have no public market price. Caplight tracks EnoPace Biomedical's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.

How much is EnoPace Biomedical worth (valuation)?

Valuation information for EnoPace Biomedical is not publicly available.

Can I buy EnoPace Biomedical stock?

EnoPace Biomedical shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.

When was EnoPace Biomedical's last funding round?

EnoPace Biomedical's most recent funding round was Early Funding on July 15, 2013.

Who are the main investors in EnoPace Biomedical?

Investor information for EnoPace Biomedical is not publicly disclosed.

Will EnoPace Biomedical IPO soon?

No public IPO plans have been announced for EnoPace Biomedical.

How can I track EnoPace Biomedical secondary market activity?

Caplight tracks bids, offers, and trades in EnoPace Biomedical's shares on secondary markets.

Firmographic Details

HeadquartersCaesarea
Employee Range10
Year Founded2008
Last FundingJul 15, 2013

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Book a demo

For institutional investors. Book with your work email.

See something wrong or outdated?